Researchers Discover New Way To Wake Up Cancer-Killing T Cells

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
Fred Hutch

CD27 - the key to long-term responses for CAR-T cell therapy?

Chimeric Antigen Receptor T (CAR-T) cell therapy is a new type of cancer treatment that has shown great promise in treating blood cancers, such as B cell lymphomas and leukemias, and multiple myeloma.
EuropaWire

University of Southampton Researchers Develop Enhanced Antibody Strategy to Boost Cancer Immunotherapy

Researchers at the University of Southampton have developed a new antibody design that boosts the immune system’s ability to fight cancer by enhancing activation of T cells through the CD27 receptor.
Seeking Alpha

Kineta Presents New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy

SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...